A total of 84 subjects with moderate risk of CVD ( GG : n = 40 ; GT/TT : n = 44 ) completed a randomized , double-blind , placebo-controlled , 8-wk crossover trial of fish-oil supplementation that provided 1.5 g LC n-3 PUFAs/d .